BVF Investments LLC files SEC Form 4 disclosures for NEUROCRINE BIOSCIENCES INC. They have made 35 open-market trades across 12 companies since 2007, most recently 2017-07-14.
CIK 0001132245
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
29 open-market purchases totalling $68.5M since 2008, against 6 sales. Across 22 scored buys the stock is down 4.8% at ninety days, and 5.1 points behind the S&P over the same stretch.
22 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -21.6% | -4.8% | -4.8% |
| Alpha | -15.8% | -5.1% | -5.1% |
| Scored | 22 | 22 | 22 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 80% | 80% |
| Avg Move | -15.9% | -0.9% | -9.6% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CAPS | SELL | 2017-07-14 | 2017-07-18 | $0.06 | $500K | -14.9% | +11.4% | +11.4% |
| CCXI | SELL | 2015-11-02 | 2015-11-02 | $6.97 | $349K | -48.7% | -9.1% | -52.8% |
| LGND | SELL | 2014-02-18 | 2014-02-20 | $73.81 | $31.2M | -9.9% | -3.4% | -3.4% |
| CCXI | BUY | 2013-11-04 | 2013-11-06 | $4.93 | $670K | -48.7% | -9.1% | -9.1% |
| CCXI | BUY | 2013-10-08 | 2013-10-10 | $5.34 | $6.9M | -48.7% | -9.1% | -9.1% |
| TRGT | BUY | 2012-11-16 | 2012-11-20 | $4.00 | $2.4M | N/A | N/A | N/A |
| NBIX | BUY | 2011-10-12 | 2011-10-14 | $5.96 | $176K | -24.3% | -5.3% | -5.3% |
| NBIX | BUY | 2011-10-10 | 2011-10-12 | $5.60 | $414K | -24.3% | -5.3% | -5.3% |
| CRA | BUY | 2011-05-10 | 2011-05-12 | $8.03 | $24.7M | N/A | N/A | N/A |
| CRA | BUY | 2011-04-20 | 2011-04-22 | $8.00 | $7.8M | N/A | N/A | N/A |
| CRA | BUY | 2011-04-07 | 2011-04-11 | $8.15 | $5.2M | N/A | N/A | N/A |
| DVAX | SELL | 2009-07-30 | 2009-08-03 | $1.85 | $29K | -2.9% | -1.7% | -1.7% |
| DVAX | SELL | 2009-04-27 | 2009-05-01 | $1.30 | $29K | -2.9% | -1.7% | -1.7% |
| NBIX | BUY | 2009-01-22 | 2009-01-26 | $3.10 | $49K | -24.3% | -5.3% | -5.3% |
| LGND | BUY | 2008-11-26 | 2008-12-01 | $1.95 | $3.1M | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2008-11-20 | 2008-11-24 | $1.76 | $344K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2008-11-14 | 2008-11-18 | $1.31 | $395K | -9.9% | -3.4% | -3.4% |
| ARQL | BUY | 2008-11-10 | 2008-11-13 | $2.35 | $5.0M | -14.3% | -3.2% | -3.2% |
| LGND | BUY | 2008-11-07 | 2008-11-12 | $1.38 | $662K | -9.9% | -3.4% | -3.4% |
| AVGN | BUY | 2008-11-06 | 2008-11-10 | $0.71 | $91K | N/A | N/A | N/A |
| ADLR | BUY | 2008-10-29 | 2008-10-31 | $2.84 | $250K | N/A | N/A | N/A |
| NBIX | BUY | 2008-10-10 | 2008-10-15 | $2.72 | $1.2M | -24.3% | -5.3% | -5.3% |
| NBIX | BUY | 2008-07-02 | 2008-07-07 | $4.17 | $157K | -24.3% | -5.3% | -5.3% |
| NBIX | BUY | 2008-05-15 | 2008-05-19 | $4.63 | $707K | -24.3% | -5.3% | -5.3% |
| NBIX | BUY | 2008-03-18 | 2008-03-19 | $4.96 | $759K | -24.3% | -5.3% | -5.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| AVGN | 7,878,915 | — |
| CRA | 18,837,217 | — |
| NPSP | 4,809,015 | — |
| ADLR | 6,182,051 | — |
| Total | $954.6M |
Shares reported on the most recent Form 4, priced at the 2017-07-18 close. 5 holdings could not be priced and are excluded from the total.
| Scored | 5 | 5 | 5 |